Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (4): 583-586    DOI: 10.12891/ceog4749.2019
Original Research Previous articles | Next articles
An observational study on diagnosis and management of adnexal masses in pregnancy
N.N. Chavan1, *(), R. Deshmukh1, N. Raj1
1Department of Obstetrics and Gynaecology, Lokmanya Tilak Municipal Medical College, Sion, Mumbai, India
Download:  PDF(436KB)  ( 183 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Background: Adnexal masses are seen in 1 in 80 to 1 in 8,000 pregnancies. However, with an increased use of ultrasonography in pregnancy, there is a significant rise in the incidence of adnexal masses in pregnancy. Objective: The study was undertaken to analyse the incidence, histological types, complications, and management of adnexal masses in pregnancy. Materials and Methods: This is an observational study of 44 cases of adnexal masses in pregnancy, performed in the Department of Obstetrics and Gynaecology LTMMC and LTMGH, Mumbai, a tertiary reference centre, during the years 2014 to 2016. Results: The incidence of adnexal masses in pregnancy was 0.2% in this study with dermoid and mucinous cyst adenoma being the most common histological types. Torsion was the most common complication seen in the study. Only 11 (25%) cases were managed conservatively. Thirty-one cases underwent exploratory laparotomy and two were managed laparoscopically. There was no significant detrimental effect on pregnancy as 79.5% of pregnancies continued until term without any complications. Conclusion: Adnexal masses in pregnancy can be effectively managed in pregnancy. Both laparotomy and laparoscopy are safe, if used judiciously.

Key words:  Adnexal mass      Pregnancy      Laparoscopy in pregnancy      Tumour markers     
Published:  10 August 2019     
*Corresponding Author(s):  N.N. CHAVAN     E-mail:  nnchavan22@gmail.com

Cite this article: 

N.N. Chavan, R. Deshmukh, N. Raj. An observational study on diagnosis and management of adnexal masses in pregnancy. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 583-586.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4749.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I4/583

[1] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[2] Saipin Pongsatha, Theera Tongsong. Intravaginal misoprostol versus sublingual misoprostol for second trimester pregnancy termination: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 122-127.
[3] Eman A. Elhosary, Mahmoud M. Ewidea, Marwa A. Mohamed. Efficacy of kinesio tape on neck pain and functional disability in pregnant women: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 175-178.
[4] Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.
[5] Khac Tu Chau, Minh Tam Le, Doan Tu Tran, Vu Quoc Huy Nguyen. Uterine torsion in a 25-week pregnant female with congenital uterine didelphys and intraoperative complication of uterine atony: a report of a rare clinical case[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 185-188.
[6] Ji Eun Park, Ji Kwon Park, Hyun Chul Jo, In Ae Cho, Jong Chul Baek. The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 79-84.
[7] Jing-Jing Jiang, Ting Han, Yan-Hui Zhu. The early second-trimester multifetal pregnancy reduction improves pregnancy outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 164-167.
[8] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[9] R. Mihăilă. Coagulation challenges in pregnancy: from thrombophilia involvement and management to the utility of thrombin generation monitoring[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 814-820.
[10] C.W. Kim, D.H. Lee, B.S. Joo, K.S. Lee. Successful cryopreservation of mouse and human blastocysts using vitrification solution without sucrose and Ficoll[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 847-855.
[11] E. Destegül, S. Gençdal, İ. Sarı, H. Akkaya, B. Çakmak, N. Gençdal. Maternal serum levels of SCUBE1 in missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 862-866.
[12] J.R. Huang, X. Li, Q.Z. Peng, J.J. Zhang, X.X. Lin, L.Q. Xie, X.H. Wu, W.S. Zhang. Elective embryo or fetal reduction for caesarean scar pregnancy combined with intrauterine pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 867-874.
[13] X.R. Wang, Y.F. Wang, S.W. Kang, Y. Zhang. Treatment outcomes of uterine lesion resection versus hysterectomy for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 882-886.
[14] J.R. Huang, X. Li, C. Fu, Y.H. Deng, T. Gao, H.W. Zhang. Is preprocessing helpful for suction and curettage in treating cesarean scar pregnancy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 900-905.
[15] L.B. Liu, H.T. Sun, S.F. Liu, R.X. Shi. Laparoscopy combined with hysteroscopy for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 911-914.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .